# Maxim (Max) Mikheev

> Maxim (Max) Mikheev is the founder, CEO and Chief Science Officer of BIOMEDICAN, Inc. His work spans molecular biology, computational modeling, genomic analysis software and engineered-yeast manufacturing. He co-founded BioDatomics and BioSoft RU and is a named co-inventor on BIOMEDICAN’s U.S. patents for cannabinoid production in yeast.

- **Role:** Founder, CEO and Chief Science Officer at BIOMEDICAN, Inc.
- **Organizations:** BIOMEDICAN, Inc., BioDatomics, BioSoft RU, University of Pittsburgh, National Institute on Aging, State Research Center of Virology and Biotechnology VECTOR
- **Education:** PhD in Molecular Biology, State Research Center of Virology and Biotechnology VECTOR, MD in Clinical and Laboratory Diagnostics, Novosibirsk State Medical University, MSc in Molecular Biology, Novosibirsk State University
- **Known for:** Co-founded BioDatomics and BioSoft RU., Named co-inventor with Difeng Gao on U.S. Patents 11,149,291 and 11,939,613., Co-authored the SPARK modeling framework paper.

## Career timeline

- **2002** — Began developing the BioUML platform with collaborators, according to his 2013 interview.
- **2006** — Moved to the United States for research work involving the National Institute on Aging and University of Pittsburgh.
- **2010** — Co-authored the SPARK agent-based modeling framework paper.
- **2011** — Formed BioDatomics to develop a genomic analysis platform.
- **2013** — BioDatomics introduced the open-source BioDT platform.
- **2017** — BIOMEDICAN was founded; Mikheev is its founder and scientific leader.
- **2021** — U.S. Patent 11,149,291, naming Mikheev and Difeng Gao, issued on October 19.
- **2023** — Co-authored Large-scale bioproduction of natural astaxanthin in Yarrowia lipolytica, published in volume 21 of Bioresource Technology Reports; available online in 2022.
- **2024** — U.S. Patent 11,939,613 issued on March 26.

## Achievements

- Co-founded BioDatomics and BioSoft RU.
- Named co-inventor with Difeng Gao on U.S. Patents 11,149,291 and 11,939,613.
- Co-authored the SPARK modeling framework paper.
- Co-authored research reporting astaxanthin fermentation in a 100-liter bioreactor.

## Latest updates

- **2024-03** — U.S. Patent 11,939,613 for Production of cannabinoids in yeast was granted, naming Maxim Mikheev and Difeng Gao as inventors.

## Links

- LinkedIn: https://www.linkedin.com/in/maxmikheev

---

Profile page: https://yespress.io/maxim-mikheev
Published by YesPress — https://yespress.io
Last updated: 2026-10-16